SCHEMBL3347321

SCHEMBL3347321

CC(C)(C)c1ccc(-c2c[nH]c(=S)[nH]2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
GFER P55789 2/20 0.58
GAA P10253 1/20 0.58
HDAC8 Q9BY41 1/20 0.55
ALDH1A1 P00352 5/20 0.51
POLB P06746 2/20 0.51
MAPT P10636 1/20 0.51
CACNA1B Q00975 1/20 0.51
APBA1 Q02410 1/20 0.51
MCL1 Q07820 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MITF O75030 1/20 0.41
TP53 P04637 1/20 0.41
KMT2A Q03164 1/20 0.41
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ALOX15 P16050 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KIF11 P52732 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3344780 0.79 GAA (0.64) KDM4EGFERGAAHDAC8ALDH1A1
SCHEMBL3342194 0.75 KDM4E (0.64) KDM4EGFERGAAHDAC8ALDH1A1
SCHEMBL3343853 0.75 GFER (0.64) KDM4EGFERGAAHDAC8ALDH1A1
SCHEMBL638777 0.74 GFER (0.58) KDM4EGFERGAAHDAC8ALDH1A1
SCHEMBL3342202 0.74 GFER (0.58) KDM4EGFERGAAHDAC8ALDH1A1
SCHEMBL3343847 0.74 ALDH1A1 (0.58) KDM4EGFERGAAHDAC8ALDH1A1
SCHEMBL258911 0.74 GAA (1.00) KDM4EGFERGAAHDAC8ALDH1A1
SCHEMBL20332635 0.74 ALDH1A1 (0.62) KDM4EALDH1A1POLBMAPTMITF
SCHEMBL6309811 0.73 KMT2A (0.55) KDM4EALDH1A1MITFTP53KMT2A
Hydrochloric Acid SCHEMBL3342876 0.72 GAA (0.96) KDM4EGFERGAAHDAC8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160401-A1 4-PHENYLIMIDAZOLE-2-THIONE TYROSINASE INHIBITORS AND TREATMENT OR PREVENTION OF PIGMENTARY DISORDERS THEREWITH GALDERMA RESEARCH & DEVELOPMENT, BIOT, FRANCE 2010-06-24 US claimed
US-20100160401-A1 4-PHENYLIMIDAZOLE-2-THIONE TYROSINASE INHIBITORS AND TREATMENT OR PREVENTION OF PIGMENTARY DISORDERS THEREWITH GALDERMA RESEARCH & DEVELOPMENT, BIOT, FRANCE 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160401-A1 4-PHENYLIMIDAZOLE-2-THIONE TYROSINASE INHIBITORS AND TREATMENT OR PREVENTION OF PIGMENTARY DISORDERS THEREWITH TYR, TH, PAH KDM4E 1018/4885GFER 2509/4885GAA 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.